We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
UFP Industries
UFPI
$4.9B
| $34K | ﹤0.01% |
+610
| New | +$33.5K |
|
627
Verisk Analytics
VRSK
$25.4B
| $34K | ﹤0.01% |
+164
| New | +$31.9K |
|
628
Wolverine World Wide
WWW
$1.61B
| $34K | ﹤0.01% |
+1,079
| New | +$31.4K |
|
|
PRFT
629
DELISTED
Perficient Inc
PRFT
| $34K | ﹤0.01% |
+708
| New | +$32.1K |
|
|
VRTU
630
DELISTED
Virtusa Corporation
VRTU
| $34K | ﹤0.01% |
+657
| New | +$33K |
|
631
Crocs
CROX
$6.14B
| $33K | ﹤0.01% |
+531
| New | +$30.3K |
|
632
Cavco Industries
CVCO
$4.22B
| $33K | ﹤0.01% |
+186
| New | +$34.5K |
|
633
Equifax
EFX
$20.3B
| $33K | ﹤0.01% |
+171
| New | +$28.7K |
|
634
Fabrinet
FN
$15.6B
| $33K | ﹤0.01% |
+428
| New | +$29.1K |
|
635
Green Dot
GDOT
$743M
| $33K | ﹤0.01% |
+590
| New | +$33.5K |
|
636
LGI Homes
LGIH
$1.27B
| $33K | ﹤0.01% |
+308
| New | +$35.1K |
|
637
LyondellBasell Industries
LYB
$20B
| $33K | ﹤0.01% |
+357
| New | +$29.1K |
|
638
Moody's
MCO
$82.8B
| $33K | ﹤0.01% |
+114
| New | +$31.9K |
|
639
MSCI
MSCI
$41.6B
| $33K | ﹤0.01% |
+74
| New | +$29K |
|
640
S&P Global
SPGI
$121B
| $33K | ﹤0.01% |
+100
| New | +$33.7K |
|
641
SPX Corp
SPXC
$11B
| $33K | ﹤0.01% |
+606
| New | +$30.4K |
|
642
Zumiez
ZUMZ
$332M
| $33K | ﹤0.01% |
+894
| New | +$30.1K |
|
|
TBRG
643
DELISTED
TruBridge
TBRG
| $33K | ﹤0.01% |
+1,218
| New | +$34.4K |
|
|
MDC
644
DELISTED
M.D.C. Holdings, Inc.
MDC
| $33K | ﹤0.01% |
+743
| New | +$33.1K |
|
|
GLUU
645
DELISTED
Glu Mobile Inc.
GLUU
| $33K | ﹤0.01% |
+3,610
| New | +$31.1K |
|
646
America's Car Mart
CRMT
$26.6M
| $32K | ﹤0.01% |
+291
| New | +$29.3K |
|
647
Dow Inc
DOW
$21.9B
| $32K | ﹤0.01% |
+584
| New | +$30.1K |
|
648
Evertec
EVTC
$1.88B
| $32K | ﹤0.01% |
+819
| New | +$30.4K |
|
649
First Trust Enhanced Short Maturity ETF
FTSM
$6.5B
| $32K | ﹤0.01% |
+547
| New | +$32.8K |
|
650
Kimco Realty
KIM
$17.2B
| $32K | ﹤0.01% |
+2,120
| New | +$28K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.